Trials / Sponsors / Hummingbird Bioscience
Hummingbird Bioscience
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HM Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer | Phase 1 / Phase 2 | 2025-12-17 |
| Recruiting | A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2024-02-05 |
| Active Not Recruiting | Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring Non-Small Cell Lung Cancer, Pancreatic Cancer, Locally Advanced Solid Tumor | Phase 1 | 2023-09-06 |
| Completed | A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Cancer, Tumor, Solid, Nonsmall Cell Lung Cancer | Phase 1 | 2022-02-28 |